| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3cd12257804e2d7f96cff826faa97e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 |
| filingDate |
2004-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3406eac39c46b539310e8ed034af885
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1f21d1a7f3d472bb692e1a541d2ba7c |
| publicationDate |
2007-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0416411-A |
| titleOfInvention |
deoxipeganine use |
| abstract |
"USE OF DEOXIPEGANIN". Deoxypeganine as a free base or as an acid addition salt or deoxypeganine derivative as long as said derivative is an acetylcholinesterase and monoamino oxidase inhibitor simultaneously may be used for the manufacture of a medicament. for the treatment of a schizophrenic psychosis. |
| priorityDate |
2003-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |